Press Releases

Recent & Archived News

June 19, 2019

Bayer's Stivarga® (regorafenib) becomes first compound used in clinical trial platform to investigate new therapies for brain cancer

Bayer announced today that the Stivarga® (regorafenib) arm of the platform trial GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment) has opened enrollment for patients with...

Learn more
June 19, 2019

Bayer Donation of $45,000 Helped Fund Development of Cook Museum of Natural Science

The Environmental Science business of Bayer is honored to have contributed $45,000 toward the development of the new Cook Museum of Natural Science that opened on June 7 in Decatur, AL. The museum...

Learn more
June 17, 2019

Bayer Launches Blue Ribbon Beekeepers, Announces Feed a Bee Grants to Celebrate National Pollinator Week

The Bayer Bee Care Program is celebrating National Pollinator Week by honoring those who are working hard to support bees and other pollinators around the country. The company announced Blue...

Learn more
June 11, 2019

Bayer Donates $50,000 to the Association of Foreign Correspondents in the United States

Bayer announces today its new partnership with the newly formed Association of Foreign Correspondents in the United States (AFC) that will provide present and future generations of journalists the...

Learn more
June 10, 2019

Ranchland Managers Have a New Tool to Fight Invasive Annual Grass

Ranchland managers who have long worried about the quality of forage available for their livestock have a new tool to fight the invasive annual grasses medusahead and ventenata. Esplanade® 200...

Learn more
June 07, 2019

Stop Invasive Annual Grasses from Destroying Western Ecosystems

An invader has been moving across the Western United States, degrading wildlife habitat, putting protected and threatened species like the Sage Grouse and desert tortoise at risk, reducing...

Learn more
June 04, 2019

Bayer and Arvinas, Inc. to develop novel Proteolysis-Targeting Chimera candidates for humans and plants

Bayer today announced a collaboration with Arvinas, Inc. (Nasdaq: ARVN), a biopharmaceutical company based in New Haven, Connecticut. The new life science research partnership uniquely leverages...

Learn more
June 03, 2019

New data on Vitrakvi® (larotrectinib) in TRK fusion cancer patients with brain metastases or primary central nervous system (CNS) tumors

Bayer today announced results of a new analysis from clinical trials investigating Vitrakvi® (larotrectinib) in patients with TRK fusion cancer with primary central nervous system (CNS) tumors or...

Learn more
May 30, 2019

Win the battle against scab and other wheat diseases with an 8.2 oz/A rate of Prosaro

Cereal diseases like scab affect grain quality and yield and rob wheat growers of profitability year after year. But growers can fight back and win with Prosaro® fungicide. The timely application...

Learn more
May 29, 2019

Bayer and Foundation Medicine announce global collaboration to develop next-generation sequencing (NGS)-based companion diagnostics in oncology

Bayer AG and Foundation Medicine, Inc. today announced a global collaboration for the development and commercialization of NGS-based companion diagnostics. This agreement allows for collaboration...

Learn more


Want even more Bayer news?

Check out our Social Media & Blogs.